Dr. Daopei Lu, Hematologist, Regenerative Medicine - Beijing, China

Dr. Daopei Lu - Stem Cell Doctor & Chief Scientist in Beijing, China

Dr. Daopei Lu stands as a luminary figure in the field of stem cell research, serving as the Chief Scientist at Beijing Bioocus Biotech Limited. With a career spanning decades, Dr. Lu has been at the forefront of groundbreaking medical advancements, particularly in hematology. His pioneering work has not only earned him recognition within China but has also garnered international acclaim.

Academic Excellence

Renowned as an academician, Dr. Lu's contributions extend far beyond the borders of his native land. As the Chief Scientist and a world-renowned hematologist, he has played a pivotal role in shaping the landscape of hematology research in China. His leadership extends to founding the Institute of Hematology at Peking University and holding distinguished professorships at prestigious institutions including Peking University, Fudan University, and Wuhan University. Dr. Lu's influence extends to his role as the Vice-Chairman of the Chinese Medical Association and his tenure as the former Vice-Chairman of the Asian Hematology Association (AHA), along with chairing the 11th International Hematology Conference. His distinguished service was further acknowledged with his induction as an Academician of the Chinese Academy of Engineering in 1996.

Pioneering Achievements

Dr. Lu's career is marked by a series of pioneering achievements that have revolutionized the field of hematology. He successfully completed the first syngeneic bone marrow transplantation in Asia in 1964, marking a significant milestone in medical history. Subsequently, he achieved the first allogeneic bone marrow transplantation in China in 1981, followed by the first major ABO-incompatible bone marrow transplantation in the late 1980s. Dr. Lu's contributions extend to groundbreaking discoveries, such as proving the efficacy of arsenic sulfide in treating certain types of leukemia and spearheading the establishment of the cord blood bank in China in 1997.

Contributions to Medical Literature

As an editor-in-chief, associate editor-in-chief, and editorial board member of multiple prestigious medical journals, Dr. Lu has been instrumental in advancing scientific discourse in the field of hematology. He has authored over 400 papers and books, including four compiled monographs such as "Leukemia Therapeutics," and has contributed to the composition of 19 publications. His editorial roles extend internationally, including membership on the editorial board of esteemed journals like Bone Marrow Transplantation and the Journal of Hematology & Oncology.

Recognition and Awards

Dr. Lu's exemplary contributions to the field have been recognized through numerous prestigious awards and honors. These include the second prize of the National Scientific and Technological Progress Award in 1985, the 7th Tan Kah Kee Prize in Medical Sciences in 1997, and the 3rd Ho Leung Ho Lee Science and Technology Progress Award in the same year. His accolades also encompass the First Prize of the Beijing Science and Technology Award in 2006, the Distinguished Service Contribution Award from CIBMTR in 2016, and the Lifetime Achievement Award from the China Anti-Cancer Association, also in 2016.

Legacy and Impact

Dr. Daopei Lu's enduring legacy extends beyond the boundaries of his remarkable career. His pioneering research and groundbreaking achievements have not only transformed the landscape of hematology but have also paved the way for future generations of medical practitioners and researchers. Through his unwavering dedication to advancing medical science, Dr. Lu continues to inspire and shape the future of stem cell research and hematology on both national and global scales.